APL Bioengineering is devoted to research at the intersection of biology, physics, and engineering. The journal publishes high-impact manuscripts specific to the understanding and advancement of physics and engineering of biological systems. APL Bioengineering is the new home for the bioengineering and biomedical research communities.

APL Bioengineering publishes original research articles, reviews, and perspectives. For more information regarding format and content types, please visit our Editorial Policies page.

Topical coverage includes:

  • Biofabrication and Bioprinting
  • Biomedical Materials, Sensors, and Imaging
  • Engineered Living Systems
  • Cell and Tissue Engineering
  • Regenerative Medicine
  • Molecular, Cell, and Tissue Biomechanics
  • Systems Biology and Computational Biology

Open Access Statement

APL Bioengineering is an open access journal. Articles published in APL Bioengineering are freely accessible, without restrictions, to the global public. Authors who publish in APL Bioengineering retain the copyright to their work under a Creative Commons license. Under this license, users are free to share and adapt the material in any format, provided appropriate credit is given. Visit the AIP Publishing Open Access Policy for more information about our policies on open access.

Journal Metrics

2023 Journal Citation Reports® (Clarivate, 2024)*:

Five-Year Impact Factor

5.8

Impact Factor

6.6

Immediacy Index

0.8

Cited Half-Life

3.0

Eigenfactor Score

0.00241

Article Influence Score

1.229

Total Citations
Q1: Engineering, Biomedical

1,444

Scopus: 
 CiteScore™†

 

9.3

Usage (2023):

295,916 Total Views

1200+ Views/Article per Year

Publication Speed (2023):

24 Days (Avg.) to 1st Decision

117 Days (Avg.) to Acceptance

138 Days (Avg.) to Publish

* Data from the 2023 Journal Citation Reports® Science Edition (Clarivate, 2024).

†CiteScore™ 2023 for AIP Publishing Journals Calculated by Scopus.

ISSN: 2473-2877
CODEN: ABPID9